{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T01:51:27Z","timestamp":1795139487937,"version":"4.10.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"The Danish Council for Strategic Research","award":["1309-00006B"],"award-info":[{"award-number":["1309-00006B"]}]},{"name":"The Novo Nordic Foundation","award":["NNF14OC0012747"],"award-info":[{"award-number":["NNF14OC0012747"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12885-015-1832-6","type":"journal-article","created":{"date-parts":[[2015,10,29]],"date-time":"2015-10-29T00:44:37Z","timestamp":1446079477000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case\u2013control study"],"prefix":"10.1186","volume":"15","author":[{"name":"On behalf of the Danish Study Group on Early Detection of Colorectal Cancer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai-Britt W.","family":"\u00d8rntoft","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans J.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torben F.","family":"\u00d8rntoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus L.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,29]]},"reference":[{"key":"1832_CR1","unstructured":"GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [database on the Internet]. International Agency for Research on Cancer. 2012. Available from: http:\/\/globocan.iarc.fr . Accessed: 31\/05\/2015"},{"issue":"5","key":"1832_CR2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1463-1318.2006.01170.x","volume":"9","author":"NC Bjerregaard","year":"2007","unstructured":"Bjerregaard NC, Tottrup A, Sorensen HT, Laurberg S. Diagnostic value of self-reported symptoms in Danish outpatients referred with symptoms consistent with colorectal cancer. Colorectal Dis. 2007;9(5):443\u201351. doi: 10.1111\/j.1463-1318.2006.01170.x .","journal-title":"Colorectal Dis"},{"issue":"19","key":"1832_CR3","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1056\/NEJM199305133281901","volume":"328","author":"JS Mandel","year":"1993","unstructured":"Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328(19):1365\u201371. doi: 10.1056\/NEJM199305133281901 .","journal-title":"N Engl J Med"},{"issue":"1","key":"1832_CR4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1463-1318.2012.03120.x","volume":"15","author":"R Pande","year":"2013","unstructured":"Pande R, Froggatt P, Baragwanath P, Harmston C. Survival outcome of patients with screening versus symptomatically detected colorectal cancers. Colorectal Dis. 2013;15(1):74\u20139. doi: 10.1111\/j.1463-1318.2012.03120.x .","journal-title":"Colorectal Dis"},{"issue":"2","key":"1832_CR5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s40291-013-0074-z","volume":"18","author":"KA Heichman","year":"2014","unstructured":"Heichman KA. Blood-based testing for colorectal cancer screening. Mol Diagn Ther. 2014;18(2):127\u201335. doi: 10.1007\/s40291-013-0074-z .","journal-title":"Mol Diagn Ther"},{"issue":"11","key":"1832_CR6","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3109\/00365521.2011.610002","volume":"46","author":"HJ Nielsen","year":"2011","unstructured":"Nielsen HJ, Jakobsen KV, Christensen IJ, Brunner N, Danish Study Group on Early Detection of Colorectal C. Screening for colorectal cancer: possible improvements by risk assessment evaluation? Scand J Gastroenterol. 2011;46(11):1283\u201394. doi: 10.3109\/00365521.2011.610002 .","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"1832_CR7","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1053\/j.gastro.2005.06.012","volume":"129","author":"CR Regueiro","year":"2005","unstructured":"Regueiro CR, Committee AGAFT. AGA Future Trends Committee report: Colorectal cancer: a qualitative review of emerging screening and diagnostic technologies. Gastroenterology. 2005;129(3):1083\u2013103. doi: 10.1053\/j.gastro.2005.06.012 .","journal-title":"Gastroenterology"},{"issue":"9","key":"1832_CR8","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1158\/1055-9965.EPI-13-0204","volume":"22","author":"U Ladabaum","year":"2013","unstructured":"Ladabaum U, Allen J, Wandell M, Ramsey S. Colorectal cancer screening with blood-based biomarkers: cost-effectiveness of methylated septin 9 DNA versus current strategies. Cancer Epidemiol Biomarkers Prev. 2013;22(9):1567\u201376. doi: 10.1158\/1055-9965.EPI-13-0204 .","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"1832_CR9","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1373\/clinchem.2008.115808","volume":"55","author":"T deVos","year":"2009","unstructured":"deVos T, Tetzner R, Model F, Weiss G, Schuster M, Distler J, et al. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem. 2009;55(7):1337\u201346. doi: 10.1373\/clinchem.2008.115808 .","journal-title":"Clin Chem"},{"issue":"6","key":"1832_CR10","volume":"9","author":"DA Johnson","year":"2014","unstructured":"Johnson DA, Barclay RL, Mergener K, Weiss G, Konig T, Beck J, et al. Plasma Septin9 versus fecal immunochemical testing for colorectal cancer screening: a prospective multicenter study. PLoS One. 2014;9(6), e98238. doi: 10.1371\/journal.pone.0098238 .","journal-title":"PLoS One"},{"issue":"2","key":"1832_CR11","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1373\/clinchem.2007.095992","volume":"54","author":"C Lofton-Day","year":"2008","unstructured":"Lofton-Day C, Model F, Devos T, Tetzner R, Distler J, Schuster M, et al. DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem. 2008;54(2):414\u201323. doi: 10.1373\/clinchem.2007.095992 .","journal-title":"Clin Chem"},{"issue":"2","key":"1832_CR12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1136\/gutjnl-2012-304149","volume":"63","author":"TR Church","year":"2014","unstructured":"Church TR, Wandell M, Lofton-Day C, Mongin SJ, Burger M, Payne SR, et al. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. Gut. 2014;63(2):317\u201325. doi: 10.1136\/gutjnl-2012-304149 .","journal-title":"Gut"},{"issue":"9","key":"1832_CR13","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1373\/clinchem.2013.221044","volume":"60","author":"NT Potter","year":"2014","unstructured":"Potter NT, Hurban P, White MN, Whitlock KD, Lofton-Day CE, Tetzner R, et al. Validation of a real-time PCR-based qualitative assay for the detection of methylated SEPT9 DNA in human plasma. Clin Chem. 2014;60(9):1183\u201391. doi: 10.1373\/clinchem.2013.221044 .","journal-title":"Clin Chem"},{"issue":"5","key":"1832_CR14","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2217\/bmm.14.8","volume":"8","author":"Y Li","year":"2014","unstructured":"Li Y, Song L, Gong Y, He B. Detection of colorectal cancer by DNA methylation biomarker SEPT9: past, present and future. Biomark Med. 2014;8(5):755\u201369. doi: 10.2217\/bmm.14.8 .","journal-title":"Biomark Med"},{"issue":"4","key":"1832_CR15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bjc.6602678","volume":"93","author":"LM McShane","year":"2005","unstructured":"McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM, et al. REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer. 2005;93(4):387\u201391. doi: 10.1038\/sj.bjc.6602678 .","journal-title":"Br J Cancer"},{"issue":"(224","key":"1832_CR16","doi-asserted-by":"crossref","first-page":"224ra24","DOI":"10.1126\/scitranslmed.3007094","volume":"6","author":"C Bettegowda","year":"2014","unstructured":"Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014;6((224):224ra24. doi: 10.1126\/scitranslmed.3007094 .","journal-title":"Sci Transl Med"},{"key":"1832_CR17","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/1471-2407-13-398","volume":"13","author":"R Wasserkort","year":"2013","unstructured":"Wasserkort R, Kalmar A, Valcz G, Spisak S, Krispin M, Toth K, et al. Aberrant septin 9 DNA methylation in colorectal cancer is restricted to a single CpG island. BMC Cancer. 2013;13:398. doi: 10.1186\/1471-2407-13-398 .","journal-title":"BMC Cancer"},{"issue":"3","key":"1832_CR18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.cgh.2011.10.008","volume":"10","author":"DA Ahlquist","year":"2012","unstructured":"Ahlquist DA, Taylor WR, Mahoney DW, Zou H, Domanico M, Thibodeau SN, et al. The stool DNA test is more accurate than the plasma septin 9 test in detecting colorectal neoplasia. Clin Gastroenterol Hepatol. 2012;10(3):272\u20137. doi: 10.1016\/j.cgh.2011.10.008 . e1.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"1832_CR19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115415","volume":"9","author":"K Toth","year":"2014","unstructured":"Toth K, Wasserkort R, Sipos F, Kalmar A, Wichmann B, Leiszter K, et al. Detection of methylated septin 9 in tissue and plasma of colorectal patients with neoplasia and the relationship to the amount of circulating cell-free DNA. PLoS One. 2014;9(12), e115415. doi: 10.1371\/journal.pone.0115415 .","journal-title":"PLoS One"},{"issue":"11","key":"1832_CR20","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/gcc.20916","volume":"50","author":"EA Peterson","year":"2011","unstructured":"Peterson EA, Stanbery L, Li C, Kocak H, Makarova O, Petty EM. SEPT9_i1 and genomic instability: mechanistic insights and relevance to tumorigenesis. Genes Chromosomes Cancer. 2011;50(11):940\u20139. doi: 10.1002\/gcc.20916 .","journal-title":"Genes Chromosomes Cancer"},{"issue":"30","key":"1832_CR21","doi-asserted-by":"crossref","first-page":"10604","DOI":"10.1073\/pnas.0500398102","volume":"102","author":"MF Fraga","year":"2005","unstructured":"Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML, et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A. 2005;102(30):10604\u20139. doi: 10.1073\/pnas.0500398102 .","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"1832_CR22","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1161\/CIRCULATIONAHA.110.956839","volume":"123","author":"DE Handy","year":"2011","unstructured":"Handy DE, Castro R, Loscalzo J. Epigenetic modifications: basic mechanisms and role in cardiovascular disease. Circulation. 2011;123(19):2145\u201356. doi: 10.1161\/CIRCULATIONAHA.110.956839 .","journal-title":"Circulation"},{"issue":"4","key":"1832_CR23","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1161\/CIRCRESAHA.116.303936","volume":"116","author":"ST Keating","year":"2015","unstructured":"Keating ST, El-Osta A. Epigenetics and metabolism. Circ Res. 2015;116(4):715\u201336. doi: 10.1161\/CIRCRESAHA.116.303936 .","journal-title":"Circ Res"},{"issue":"11","key":"1832_CR24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003759","volume":"3","author":"R Grutzmann","year":"2008","unstructured":"Grutzmann R, Molnar B, Pilarsky C, Habermann JK, Schlag PM, Saeger HD, et al. Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PLoS One. 2008;3(11), e3759. doi: 10.1371\/journal.pone.0003759 .","journal-title":"PLoS One"},{"issue":"9","key":"1832_CR25","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1177\/0961203311399606","volume":"20","author":"E Bartoloni","year":"2011","unstructured":"Bartoloni E, Ludovini V, Alunno A, Pistola L, Bistoni O, Crino L, et al. Increased levels of circulating DNA in patients with systemic autoimmune diseases: A possible marker of disease activity in Sjogren\u2019s syndrome. Lupus. 2011;20(9):928\u201335. doi: 10.1177\/0961203311399606 .","journal-title":"Lupus"},{"issue":"11","key":"1832_CR26","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1172\/JCI105479","volume":"45","author":"EM Tan","year":"1966","unstructured":"Tan EM, Schur PH, Carr RI, Kunkel HG. Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest. 1966;45(11):1732\u201340. doi: 10.1172\/JCI105479 .","journal-title":"J Clin Invest"},{"issue":"9","key":"1832_CR27","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1373\/clinchem.2006.084509","volume":"53","author":"XY Zhong","year":"2007","unstructured":"Zhong XY, von Muhlenen I, Li Y, Kang A, Gupta AK, Tyndall A, et al. Increased concentrations of antibody-bound circulatory cell-free DNA in rheumatoid arthritis. Clin Chem. 2007;53(9):1609\u201314. doi: 10.1373\/clinchem.2006.084509 .","journal-title":"Clin Chem"},{"key":"1832_CR28","doi-asserted-by":"crossref","unstructured":"Ai R, Whitaker JW, Boyle DL, Tak PP, Gerlag DM, Wang W et al. DNA methylome signature in early rheumatoid arthritis synoviocytes compared with longstanding rheumatoid arthritis synoviocytes. Arthritis Rheum. 2015. doi:10.1002\/art.39123","DOI":"10.1002\/art.39123"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1832-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T18:27:16Z","timestamp":1498242436000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2407\/15\/819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,29]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1832"],"URL":"https:\/\/doi.org\/10.1186\/s12885-015-1832-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,29]]},"article-number":"819"}}